Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of different concentrations of ropivacaine with hydromorphone for rapid rehabilitation after total hip arthroplasty
ChiCTR2300073718Phase 4Completed
- Sponsor
- The Second Hospital of Jilin University
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine and hydromorphone in Neck Of Femur Fracture, osteonecrosis of the hip and ankylosing spondylitis (AS) (3 arms), sponsored by The Second Hospital of Jilin University. Primary endpoints: Time of hospitalization, Time to get out of bed from the end of surgery and 1 more. Started Dec 2020; status: completed.
02
Drugs
ropivacainehydromorphone
03
Conditions
Neck Of Femur Fractureosteonecrosis of the hipankylosing spondylitis (AS)
Beyond the preview
Go deeper on ChiCTR2300073718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073718.